Company / Operating Cash Flow per Share
Oric Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.26
FY2025
5-year range
-$1.89 / -$1.26
FY2021-FY2025
Trend
+21.8%
vs FY2024
Sector context
#125 of 212
Health Care
What the data says
At $-1.26, Oric Pharmaceuticals, Inc.'s operating cash flow per share ranks #125 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 3 consecutive years, from $-1.89 in FY2022 to $-1.26 in FY2025.
Based on SEC 10-K filings.
-1.26 in FY2025.
Improved from $-1.67 to $-1.26 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#125 of 212 in Health CareTop 59% of 212This company -$1.26 Sector average -$14.72
▼
+91.4% above sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 21.8% year-over-year.
- Ranks #125 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.26 | +21.8% |
| FY2024 | -$1.62 | +3.0% |
| FY2023 | -$1.67 | +12.1% |
| FY2022 | -$1.89 | -20.8% |
| FY2021 | -$1.57 | +24.0% |
| FY2020 | -$2.06 | +83.3% |
| FY2019 | -$12.39 | -3.9% |
| FY2018 | -$11.93 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026